Home › Trial NCT04250597
Study of GNX102 in Patients With Advanced Solid Tumors
- Trial IDNCT04250597
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorGlycoNex, Inc.
- Enrollment46
- Start date2020-07-29
- ConditionsSolid Tumor · Metastatic Cancer · Advanced Cancer · Unresectable Solid Neoplasm
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.